New York, NY (November 5, 2018) — This year's Eric D. Hadar Distinguished Lecture at the Columbia University Department of Psychiatry will take place on November 7th, 2018. This year's lecturer will be Dr. Kathleen M. Carroll, who will present her talk, "Adventures in the dissemination of evidence-based therapies," at 11:00 am at 1051 Riverside Drive in the Hellman Auditorium.
This event is a part of the annual lecture series on substance use disorders sponsored by the Eric D. Hadar Family Foundation. The Foundation's generous commitment of $2 million was given to support the work of the Division on Substance Use Disorders. A portion of this gift included an endowed fund of $750,000 for the annual Hadar Distinguished Lecture. The remaining amount established the Eric D. Hadar Research Fund, advancing research by providing resources for fellowship and faculty support, research projects, and laboratory infrastructure.
"We are in the midst of an unprecedented epidemic never before seen in the history of the disease of addiction. It is absolutely critical that we focus as many resources as possible to learn about this disease and educate ourselves and others, as well as explore more effective treatment methods," said Eric Hadar, founder of the Eric D. Hadar Family Foundation. Hadar is Chairman and CEO of Allied Partners, the real estate investment, development, and asset management company he founded in 1993. He also is a member of the Samaritan Daytop Foundation Board of Trustees, which raises money to support Samaritan Daytop Village, a human services agency that provides addiction recovery and support.
Since 2016, the Eric D. Hadar Distinguished Lecture series has expanded understanding of both substance use and the treatments available to those dealing with these disorders. Previous speakers include Dr. Paula Riggs, the Director of the Division of Substance Dependence at the University of Colorado Denver, who spoke on the public health impact and clinical implications of Marijuana Legalization; and Professor Sir John Strang, the head of the National Addictions Centre at Kings College London, who spoke on preventing opiate overdose deaths.
Dr. Kathleen M. Carroll graduated summa cum laude from Duke University, received her Ph.D. in clinical psychology in 1988 from the University of Minnesota, and completed her pre-doctoral training at the Yale University School of Medicine's Division of Substance Abuse, where she was promoted to Professor in 2002. She is Principal Investigator of the Center for Psychotherapy Development at Yale, NIDA's only Center devoted to behavioral therapies research; since 1999 she has been Principal Investigator of the New England Node of the National Institute on Drug Abuse's Clinical Trials Network (merging with Dr. Roger Weiss' Northern New England Node in 2009). Dr. Carroll is the author of over 320 peer-reviewed publications as well as numerous chapters and books. Her research has focused on the development and evaluation of effective combinations of behavioral therapies and pharmacotherapies, with an emphasis on improving the quality and rigor of clinical efficacy research in the addictions and the quality of substance abuse treatment overall.
The Stage Model of Behavioral Therapies development is a useful framework conceptualizing how effective treatments can be developed, evaluated and moved into the treatment system. Dr. Carroll will describe her work over the last 35 years on moving validated behavioral therapies from the research clinic to the real world via the Stage Model. Her work was originally, and continues to be, inspired by the late Dr. Herbert D. Kleber, who devoted his life to improving treatment and outcomes for individuals with substance use disorder. As addiction researchers, we can honor Dr. Kleber's incredible legacy by focusing our work on making the treatment system more accessible, more equitable, and more effective.
###
Columbia University Department of Psychiatry
Columbia Psychiatry is among the top ranked psychiatry departments in the nation and has contributed greatly to the understanding and treatment of brain disorders. Co-located at the New York State Psychiatric Institute on the NewYork-Presbyterian Hospital/Columbia University Irving Medical Center campus in Washington Heights, the department enjoys a rich and productive collaborative relationship with physicians in various disciplines at the Columbia University Vagelos College of Physicians and Surgeons. Columbia Psychiatry is home to distinguished clinicians and researchers noted for their clinical and research advances in the diagnosis and treatment of depression, suicide, schizophrenia, bipolar and anxiety disorders, eating disorders, substance use disorders, and childhood psychiatric disorders.
Media Contact
Eian Kantor
[email protected]
646-774-5368
@ColumbiaMed
http://www.cumc.columbia.edu
